389 related articles for article (PubMed ID: 25673747)
21. The p75 neurotrophin receptor augments survival signaling in the striatum of pre-symptomatic Q175(WT/HD) mice.
Wehner AB; Milen AM; Albin RL; Pierchala BA
Neuroscience; 2016 Jun; 324():297-306. PubMed ID: 26947127
[TBL] [Abstract][Full Text] [Related]
22. Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.
Farrar AM; Callahan JW; Abercrombie ED
Exp Neurol; 2011 Dec; 232(2):119-25. PubMed ID: 21864528
[TBL] [Abstract][Full Text] [Related]
23. Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease.
Galvan L; André VM; Wang EA; Cepeda C; Levine MS
J Huntingtons Dis; 2012; 1(1):17-25. PubMed ID: 25063187
[TBL] [Abstract][Full Text] [Related]
24. Striatal network modeling in Huntington's Disease.
Ponzi A; Barton SJ; Bunner KD; Rangel-Barajas C; Zhang ES; Miller BR; Rebec GV; Kozloski J
PLoS Comput Biol; 2020 Apr; 16(4):e1007648. PubMed ID: 32302302
[TBL] [Abstract][Full Text] [Related]
25. Complete but not partial inhibition of glutamate transporters exacerbates cortical excitability in the R6/2 mouse model of Huntington's disease.
Estrada-Sánchez AM; Castro D; Portillo-Ortiz K; Jang K; Nedjat-Haiem M; Levine MS; Cepeda C
CNS Neurosci Ther; 2019 Apr; 25(4):509-518. PubMed ID: 30311425
[TBL] [Abstract][Full Text] [Related]
26. Calcium dysregulation and compensation in cortical pyramidal neurons of the R6/2 mouse model of Huntington's disease.
Oikonomou KD; Donzis EJ; Bui MTN; Cepeda C; Levine MS
J Neurophysiol; 2021 Oct; 126(4):1159-1171. PubMed ID: 34469694
[TBL] [Abstract][Full Text] [Related]
27. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS
J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510
[TBL] [Abstract][Full Text] [Related]
28. Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington's Disease Mice.
Holley SM; Galvan L; Kamdjou T; Dong A; Levine MS; Cepeda C
Front Synaptic Neurosci; 2019; 11():14. PubMed ID: 31139071
[TBL] [Abstract][Full Text] [Related]
29. Age- and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington's disease.
Padovan-Neto FE; Jurkowski L; Murray C; Stutzmann GE; Kwan M; Ghavami A; Beaumont V; Park LC; West AR
Nitric Oxide; 2019 Feb; 83():40-50. PubMed ID: 30528913
[TBL] [Abstract][Full Text] [Related]
30. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
Starling AJ; André VM; Cepeda C; de Lima M; Chandler SH; Levine MS
J Neurosci Res; 2005 Nov; 82(3):377-86. PubMed ID: 16211559
[TBL] [Abstract][Full Text] [Related]
31. Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease.
Covey DP; Dantrassy HM; Zlebnik NE; Gildish I; Cheer JF
J Neurosci; 2016 May; 36(18):4993-5002. PubMed ID: 27147652
[TBL] [Abstract][Full Text] [Related]
32. Cortico-Striatal Cross-Frequency Coupling and Gamma Genesis Disruptions in Huntington's Disease Mouse and Computational Models.
Naze S; Humble J; Zheng P; Barton S; Rangel-Barajas C; Rebec GV; Kozloski JR
eNeuro; 2018; 5(6):. PubMed ID: 30627632
[TBL] [Abstract][Full Text] [Related]
33. TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration.
Creus-Muncunill J; Haure-Mirande JV; Mattei D; Bons J; Ramirez AV; Hamilton BW; Corwin C; Chowdhury S; Schilling B; Ellerby LM; Ehrlich ME
J Neuroinflammation; 2024 Mar; 21(1):66. PubMed ID: 38459557
[TBL] [Abstract][Full Text] [Related]
34. Reduced tonic inhibition in striatal output neurons from Huntington mice due to loss of astrocytic GABA release through GAT-3.
Wójtowicz AM; Dvorzhak A; Semtner M; Grantyn R
Front Neural Circuits; 2013; 7():188. PubMed ID: 24324407
[TBL] [Abstract][Full Text] [Related]
35. Early impairment of thalamocortical circuit activity and coherence in a mouse model of Huntington's disease.
Shobe JL; Donzis EJ; Lee K; Chopra S; Masmanidis SC; Cepeda C; Levine MS
Neurobiol Dis; 2021 Sep; 157():105447. PubMed ID: 34274461
[TBL] [Abstract][Full Text] [Related]
36. Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease.
Schmidt ME; Buren C; Mackay JP; Cheung D; Dal Cengio L; Raymond LA; Hayden MR
BMC Biol; 2018 Jun; 16(1):58. PubMed ID: 29945611
[TBL] [Abstract][Full Text] [Related]
37. Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice.
Naydenov AV; Sepers MD; Swinney K; Raymond LA; Palmiter RD; Stella N
Neurobiol Dis; 2014 Nov; 71():140-50. PubMed ID: 25134728
[TBL] [Abstract][Full Text] [Related]
38. Striatal potassium channel dysfunction in Huntington's disease transgenic mice.
Ariano MA; Cepeda C; Calvert CR; Flores-Hernández J; Hernández-Echeagaray E; Klapstein GJ; Chandler SH; Aronin N; DiFiglia M; Levine MS
J Neurophysiol; 2005 May; 93(5):2565-74. PubMed ID: 15625098
[TBL] [Abstract][Full Text] [Related]
39. Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism.
Warre R; Thiele S; Talwar S; Kamal M; Johnston TH; Wang S; Lam D; Lo C; Khademullah CS; Perera G; Reyes G; Sun XS; Brotchie JM; Nash JE
Neurobiol Dis; 2011 Mar; 41(3):591-604. PubMed ID: 20971190
[TBL] [Abstract][Full Text] [Related]
40. Single-Nucleus RNA-Seq Reveals Dysregulation of Striatal Cell Identity Due to Huntington's Disease Mutations.
Malaiya S; Cortes-Gutierrez M; Herb BR; Coffey SR; Legg SRW; Cantle JP; Colantuoni C; Carroll JB; Ament SA
J Neurosci; 2021 Jun; 41(25):5534-5552. PubMed ID: 34011527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
